- Home
- ATR vs PCVX Comparison
ATR vs PCVX Comparison
Compare ATR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATR
- PCVX
- Stock Information
- Founded
- ATR 1992
- PCVX 2013
- Country
- ATR United States
- PCVX United States
- Employees
- ATR N/A
- PCVX N/A
- Industry
- ATR Plastic Products
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ATR Industrials
- PCVX Health Care
- Exchange
- ATR Nasdaq
- PCVX Nasdaq
- Market Cap
- ATR 10.4B
- PCVX 11.5B
- IPO Year
- ATR 1993
- PCVX 2020
- Fundamental
- Price
- ATR $146.40
- PCVX $79.74
- Analyst Decision
- ATR Strong Buy
- PCVX Strong Buy
- Analyst Count
- ATR 5
- PCVX 8
- Target Price
- ATR $183.75
- PCVX $127.71
- AVG Volume (30 Days)
- ATR 449.0K
- PCVX 913.0K
- Earning Date
- ATR 02-06-2025
- PCVX 02-25-2025
- Dividend Yield
- ATR 1.23%
- PCVX N/A
- EPS Growth
- ATR 30.12
- PCVX N/A
- EPS
- ATR 5.53
- PCVX N/A
- Revenue
- ATR $3,582,890,000.00
- PCVX N/A
- Revenue This Year
- ATR $2.82
- PCVX N/A
- Revenue Next Year
- ATR $5.54
- PCVX N/A
- P/E Ratio
- ATR $26.46
- PCVX N/A
- Revenue Growth
- ATR 2.74
- PCVX N/A
- 52 Week Low
- ATR $135.96
- PCVX $58.10
- 52 Week High
- ATR $178.03
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- ATR 37.00
- PCVX 36.96
- Support Level
- ATR $139.93
- PCVX $82.03
- Resistance Level
- ATR $147.49
- PCVX $84.10
- Average True Range (ATR)
- ATR 3.65
- PCVX 3.12
- MACD
- ATR -0.08
- PCVX -0.70
- Stochastic Oscillator
- ATR 32.50
- PCVX 1.88
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.